Europe - Frankfurt Stock Exchange - FRA:ILM1 - DE000A1MMCC8 - Common Stock
The current stock price of ILM1.DE is 15.4 EUR. In the past month the price increased by 5.31%. In the past year, price increased by 24.05%.
ChartMill assigns a technical rating of 10 / 10 to ILM1.DE. When comparing the yearly performance of all stocks, ILM1.DE is one of the better performing stocks in the market, outperforming 84.68% of all stocks.
ChartMill assigns a fundamental rating of 5 / 10 to ILM1.DE. ILM1.DE has an excellent financial health rating, but there are some minor concerns on its profitability.
Over the last trailing twelve months ILM1.DE reported a non-GAAP Earnings per Share(EPS) of 0.87. The EPS increased by 63.63% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 1.09% | ||
| ROA | 2.34% | ||
| ROE | 4.25% | ||
| Debt/Equity | 0.32 |
12 analysts have analysed ILM1.DE and the average price target is 24.14 EUR. This implies a price increase of 56.75% is expected in the next year compared to the current price of 15.4.
For the next year, analysts expect an EPS growth of 4.73% and a revenue growth 8.28% for ILM1.DE
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| AMP.MI | AMPLIFON SPA | 26.02 | 3.12B | ||
| AXNA.DE | AMPLIFON SPA | 26 | 3.12B | ||
| FAGR.BR | FAGRON | 18.68 | 1.61B | ||
| UPR.I | UNIPHAR PLC | 16.75 | 956.52M | ||
| BLC.PA | BASTIDE LE CONFORT MEDICAL | 357.14 | 184.25M | ||
| VMED.DE | VIROMED MEDICAL AG | N/A | 82.62M |
Medios AG is a holding company, which engages in the provision of pharmaceutical drugs. The company is headquartered in Berlin, Berlin and currently employs 999 full-time employees. The firm covers relevant aspects of supply chain like from pharmaceutical supply and manufacture of patient-specific therapies, including blistering and others. The company operates in two segments Pharmaceutical supply which focuses on pharmaceutical wholesale with finished specialty pharma (high-priced drugs for rare and chronic diseases) medications including oncology, neurology, autoimmunology, ophthalmology, infectiology, hemophilia along with offering finished medicinal products; Patient-specific therapies focusing on pharmaceutical manufacturing of patient-specific preparations such as Cytostatic infusions, Antibody therapies, Virostatic and antibiotic medications, Parenteral nutrition solutions, Investigational medicinal products are among others. Its products and services include Patient health & protection and procedures & processes for patient care and digitalization of data.
MEDIOS AG
Heidestrasse 9
Berlin BERLIN DE
Employees: 999
Phone: 4930232566800
Medios AG is a holding company, which engages in the provision of pharmaceutical drugs. The company is headquartered in Berlin, Berlin and currently employs 999 full-time employees. The firm covers relevant aspects of supply chain like from pharmaceutical supply and manufacture of patient-specific therapies, including blistering and others. The company operates in two segments Pharmaceutical supply which focuses on pharmaceutical wholesale with finished specialty pharma (high-priced drugs for rare and chronic diseases) medications including oncology, neurology, autoimmunology, ophthalmology, infectiology, hemophilia along with offering finished medicinal products; Patient-specific therapies focusing on pharmaceutical manufacturing of patient-specific preparations such as Cytostatic infusions, Antibody therapies, Virostatic and antibiotic medications, Parenteral nutrition solutions, Investigational medicinal products are among others. Its products and services include Patient health & protection and procedures & processes for patient care and digitalization of data.
The current stock price of ILM1.DE is 15.4 EUR. The price increased by 2.26% in the last trading session.
ILM1.DE does not pay a dividend.
ILM1.DE has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
ILM1.DE stock is listed on the Frankfurt Stock Exchange exchange.
12 analysts have analysed ILM1.DE and the average price target is 24.14 EUR. This implies a price increase of 56.75% is expected in the next year compared to the current price of 15.4.
You can find the ownership structure of MEDIOS AG (ILM1.DE) on the Ownership tab.